Pierre J. Lefèbvre

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Vitamin E Reduction of Protein Glycosylation in Diabetes: New Prospect for Prevention of Diabetic Complications?

Antonio Ceriello, Dario Giugliano, Antonio Quatraro et al. · Diabetes Care · 1991 · 273 citations

Medicine, Biochemistry, Nutrition +15

Glucagon: molecular physiology, clinical and therapeutic implications

Pierre J. Lefèbvre, Roger H. Unger · 1972 · 268 citations

Life Sciences, Endocrinology, Physiology +11

Risk of Developing Retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control

LiYing Zhang, G. Krzentowski, Adelin Albert et al. · Diabetes Care · 2001 · 260 citations · Full text

Medicine, Ophthalmology, Clinical Vision Science +15

No Increased Insulin Sensitivity after a Single Intravenous Administration of a Recombinant Human Tumor Necrosis Factor Receptor: Fc Fusion Protein in Obese Insulin-Resistant Patients*

Nicolas Paquot, Manuel J. Castillo, Pierre J. Lefèbvre et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 200 citations · Full text

Medicine, Endocrinology, Pharmacology +11